Gentex Is Maintained at Neutral by B of A Securities
BofA Securities Maintains Gentex(GNTX.US) With Hold Rating, Announces Target Price $35
Baird Maintains Gentex(GNTX.US) With Buy Rating, Cuts Target Price to $35
UBS Maintains Gentex(GNTX.US) With Hold Rating, Cuts Target Price to $32
Gentex Analyst Ratings
Goldman Sachs Maintains Gentex(GNTX.US) With Hold Rating, Announces Target Price $31
Gentex Price Target Announced at $34.00/Share by UBS
Gentex Analyst Ratings
UBS Initiates Gentex(GNTX.US) With Hold Rating, Announces Target Price $34
BNP Paribas Exane Downgrades Gentex to Neutral From Outperform, Price Target Is $34
BNP Paribas Initiates Gentex(GNTX.US) With Hold Rating, Announces Target Price $34
B.Riley Financial Maintains Gentex(GNTX.US) With Buy Rating, Cuts Target Price to $41
J.P. Morgan Maintains Gentex(GNTX.US) With Hold Rating, Cuts Target Price to $34
Baird Maintains Gentex(GNTX.US) With Buy Rating, Cuts Target Price to $38
Gentex Analyst Ratings
Baird Maintains Outperform on Gentex, Lowers Price Target to $38
Analysts' Opinions Are Mixed on These Consumer Cyclical Stocks: Carter's (CRI), Newell Brands (NWL) and Gentex (GNTX)
Goldman Sachs Maintains Gentex(GNTX.US) With Hold Rating
JPMorgan Adjusts Price Target on Gentex to $35 From $36, Maintains Neutral Rating
JP Morgan Maintains Neutral on Gentex, Lowers Price Target to $35